Nvidia (NVDA) Stocks Faces ‘Make or Break’ Moment, Says Wolfe Research
Nvidia (NVDA) and other momentum stocks face a make or break moment as the bull market in U.S. equities shows signs of ...
Mass layoffs of federal workers could hurt families and local economies — but may not dent the overall economy
Elon Musk, wielding a chainsaw, is overseeing a rapid shrinking of the nation’s largest employer: the federal government.
1 Wall Street Analyst Thinks Snowflake Stock Is Going to $235. Is It a Buy?
For the stock to hit the analyst's $235 price target, Snowflake will have to meet Wall Street's consensus estimate for $4.43 billion in revenue next year and trade at the same P/S multiple. That would ...
Wolfe Research Downgrades Robinhood Markets (NASDAQ:HOOD) to Peer Perform
Wolfe Research lowered shares of Robinhood Markets (NASDAQ:HOOD – Free Report) from an outperform rating to a peer perform ...
Yahoo Finance8d
Wolfe downgrades Datadog on growth concerns, upgrades Snowflake on improving trend
Investing.com -- Wolfe Research downgraded Datadog (NASDAQ:DDOG) to "Peer Perform" from "Outperform" on weaker-than-expected fiscal 2025 growth guidance, competitive pressures, and margin concerns.
Why the spring selling season is going to be 'challenging' for homebuilders
The spring home-selling season is shaping up to be a challenging one for major homebuilders amid a trade war and rising mortgage rates.
Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering
Kestra Medical Technologies, Ltd. ("Kestra"), a wearable medical device and digital healthcare company, today announced the launch of its initial public ...
Yahoo Finance8d
Robinhood downgraded to Peer Perform from Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak downgraded Robinhood (HOOD) to Peer Perform from Outperform and removed the firm’s prior $51 price target Since the firm’s previous upgrade of the shares ...
TipRanks on MSN5d
Illumina weakness ‘overdone,’ says Wolfe Research
Wolfe Research reiterated an Outperform rating and $150 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about its ...